Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 94

1.

[Mucosal-associated invariant T cells].

Rouxel O, Lehuen A.

Med Sci (Paris). 2018 Jun-Jul;34(6-7):518-522. doi: 10.1051/medsci/20183406008. Epub 2018 Jul 31. French. No abstract available.

PMID:
30067221
2.

Mucosal-associated invariant T (MAIT) cells are depleted and prone to apoptosis in cardiometabolic disorders.

Touch S, Assmann KE, Aron-Wisnewsky J, Marquet F, Rouault C, Fradet M, Mosbah H, Consortium M, Isnard R, Helft G, Lehuen A, Poitou C, Clément K, André S; MetaCardis Consortium.

FASEB J. 2018 Apr 27:fj201800052RR. doi: 10.1096/fj.201800052RR. [Epub ahead of print]

PMID:
29957059
3.

Author Correction: Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes.

Rouxel O, DaSilva J, Beaudoin L, Nel I, Tard C, Cagninacci L, Kiaf B, Oshima M, Diedisheim M, Salou M, Corbett A, Rossjohn J, McCluskey J, Scharfmann R, Battaglia M, Polak M, Lantz O, Beltrand J, Lehuen A.

Nat Immunol. 2018 Sep;19(9):1035. doi: 10.1038/s41590-017-0023-9.

PMID:
29880894
4.

Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver.

Hegde P, Weiss E, Paradis V, Wan J, Mabire M, Sukriti S, Rautou PE, Albuquerque M, Picq O, Gupta AC, Ferrere G, Gilgenkrantz H, Kiaf B, Toubal A, Beaudoin L, Lettéron P, Moreau R, Lehuen A, Lotersztajn S.

Nat Commun. 2018 Jun 1;9(1):2146. doi: 10.1038/s41467-018-04450-y.

5.

Mucosal-associated invariant T cells in autoimmune and immune-mediated diseases.

Rouxel O, Lehuen A.

Immunol Cell Biol. 2018 Jul;96(6):618-629. doi: 10.1111/imcb.12011. Epub 2018 Mar 2. Review.

PMID:
29405379
6.

Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes.

Rouxel O, Da Silva J, Beaudoin L, Nel I, Tard C, Cagninacci L, Kiaf B, Oshima M, Diedisheim M, Salou M, Corbett A, Rossjohn J, McCluskey J, Scharfmann R, Battaglia M, Polak M, Lantz O, Beltrand J, Lehuen A.

Nat Immunol. 2017 Dec;18(12):1321-1331. doi: 10.1038/ni.3854. Epub 2017 Oct 9. Erratum in: Nat Immunol. 2018 Jun 7;:.

7.

Intestinal invalidation of the glucose transporter GLUT2 delays tissue distribution of glucose and reveals an unexpected role in gut homeostasis.

Schmitt CC, Aranias T, Viel T, Chateau D, Le Gall M, Waligora-Dupriet AJ, Melchior C, Rouxel O, Kapel N, Gourcerol G, Tavitian B, Lehuen A, Brot-Laroche E, Leturque A, Serradas P, Grosfeld A.

Mol Metab. 2016 Nov 4;6(1):61-72. doi: 10.1016/j.molmet.2016.10.008. eCollection 2017 Jan.

8.

IRF5 governs liver macrophage activation that promotes hepatic fibrosis in mice and humans.

Alzaid F, Lagadec F, Albuquerque M, Ballaire R, Orliaguet L, Hainault I, Blugeon C, Lemoine S, Lehuen A, Saliba DG, Udalova IA, Paradis V, Foufelle F, Venteclef N.

JCI Insight. 2016 Dec 8;1(20):e88689.

9.

Defective Invariant Natural Killer T-Cell Suppression in Patients With Type 1 Diabetes.

Nel I, Lehuen A.

Diabetes. 2016 Aug;65(8):2121-3. doi: 10.2337/dbi16-0021. No abstract available.

10.

Ablation of interaction between IL-33 and ST2+ regulatory T cells increases immune cell-mediated hepatitis and activated NK cell liver infiltration.

Noel G, Arshad MI, Filliol A, Genet V, Rauch M, Lucas-Clerc C, Lehuen A, Girard JP, Piquet-Pellorce C, Samson M.

Am J Physiol Gastrointest Liver Physiol. 2016 Aug 1;311(2):G313-23. doi: 10.1152/ajpgi.00097.2016. Epub 2016 Jun 23.

11.

SLAM-associated protein favors the development of iNKT2 over iNKT17 cells.

Michel ML, Lenoir C, Massot B, Diem S, Pasquier B, Sawa S, Rignault-Bricard R, Lehuen A, Eberl G, Veillette A, Leite-de-Moraes M, Latour S.

Eur J Immunol. 2016 Sep;46(9):2162-74. doi: 10.1002/eji.201646313. Epub 2016 Jul 22.

12.

Regulatory role of natural killer T cells in diabetes.

Tard C, Rouxel O, Lehuen A.

Biomed J. 2015 Dec;38(6):484-95. doi: 10.1016/j.bj.2015.04.001. Epub 2016 Mar 10. Review.

13.

Lights on MAIT cells, a new immune player in liver diseases.

Toubal A, Lehuen A.

J Hepatol. 2016 May;64(5):1008-1010. doi: 10.1016/j.jhep.2016.02.003. Epub 2016 Feb 8. No abstract available.

PMID:
26867492
14.

[Mucosal-associated invariant T cells in obesity and type 2 diabetes].

Magalhaes I, Lehuen A.

Med Sci (Paris). 2015 Aug-Sep;31(8-9):717-9. doi: 10.1051/medsci/20153108005. Epub 2015 Sep 4. French. No abstract available.

15.

iNKT and MAIT Cell Alterations in Diabetes.

Magalhaes I, Kiaf B, Lehuen A.

Front Immunol. 2015 Jul 2;6:341. doi: 10.3389/fimmu.2015.00341. eCollection 2015. Review.

16.

Regulatory Role of Natural Killer T Cells in Diabetes.

Tard C, Rouxel O, Lehuen A.

Biomed J. 2015 Jun 12. doi: 10.4103/2319-4170.158622. [Epub ahead of print]

17.

Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients.

Magalhaes I, Pingris K, Poitou C, Bessoles S, Venteclef N, Kiaf B, Beaudoin L, Da Silva J, Allatif O, Rossjohn J, Kjer-Nielsen L, McCluskey J, Ledoux S, Genser L, Torcivia A, Soudais C, Lantz O, Boitard C, Aron-Wisnewsky J, Larger E, Clément K, Lehuen A.

J Clin Invest. 2015 Apr;125(4):1752-62. doi: 10.1172/JCI78941. Epub 2015 Mar 9.

18.

A double-edged sword against type 1 diabetes.

Lehuen A.

N Engl J Med. 2015 Feb 19;372(8):778-80. doi: 10.1056/NEJMcibr1414708. No abstract available.

PMID:
25693020
19.

IgA, IgA receptors, and their anti-inflammatory properties.

Mkaddem SB, Christou I, Rossato E, Berthelot L, Lehuen A, Monteiro RC.

Curr Top Microbiol Immunol. 2014;382:221-35. doi: 10.1007/978-3-319-07911-0_10. Review.

PMID:
25116102
20.

Supplemental Content

Loading ...
Support Center